Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Jorge Revilla Beltri, MD
CONTACT
Aaron Molina Perez, MD
CONTACT
Lead
Probiomed S.A. de C.V.
At present R-CHOP (Rituximab plus Cyclofosfamide, Doxorrubicine, Vincristine and Prednisone) has became standard of care of patients with B cells Non Hodgkin Lymphoma CD20+. Study will perform pharmacodynamic (PD) and pharmacokinetic (PK) measurment of a novel Rituximab in comparison with Mabthera and evaluates safety both metabolic as well immunologic. Study protocolo is designed to provide data on impact of treatment interchange of both study drugs (PBO-326 and Mabthera).
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted